期刊文献+

Insight to drug delivery aspects for colorectal cancer 被引量:4

Insight to drug delivery aspects for colorectal cancer
下载PDF
导出
摘要 Colorectal cancer(CRC) is the third most common cancer diagnosed worldwide in human beings. Surgery, chemotherapy, radiotherapy and targeted therapiesare the conventional four approaches which are currently used for the treatment of CRC. The site specific delivery of chemotherapeutics to their site of action would increase effectiveness with reducing side effects. Targeted oral drug delivery systems based on polysaccharides are being investigated to target and deliver chemotherapeutic and chemopreventive agents directly to colon and rectum. Site-specific drug delivery to colon increases its concentration at the target site, and thus requires a lower dose and hence abridged side effects. Some novel therapies are also briefly discussed in article such as receptor(epidermal growth factor receptor, folate receptor, wheat germ agglutinin, VEGF receptor, hyaluronic acid receptor) based targeting therapy; colon targeted proapoptotic anticancer drug delivery system, gene therapy. Even though good treatment options are available for CRC, the ultimate therapeutic approach is to avert the incidence of CRC. It was also found that CRCs could be prevented by diet and nutrition such as calcium, vitamin D, curcumin, quercetin and fish oil supplements. Immunotherapy and vaccination are used nowadays which are showing better results against CRC. Colorectal cancer(CRC) is the third most common cancer diagnosed worldwide in human beings. Surgery, chemotherapy, radiotherapy and targeted therapiesare the conventional four approaches which are currently used for the treatment of CRC. The site specific delivery of chemotherapeutics to their site of action would increase effectiveness with reducing side effects. Targeted oral drug delivery systems based on polysaccharides are being investigated to target and deliver chemotherapeutic and chemopreventive agents directly to colon and rectum. Site-specific drug delivery to colon increases its concentration at the target site, and thus requires a lower dose and hence abridged side effects. Some novel therapies are also briefly discussed in article such as receptor(epidermal growth factor receptor, folate receptor, wheat germ agglutinin, VEGF receptor, hyaluronic acid receptor) based targeting therapy; colon targeted proapoptotic anticancer drug delivery system, gene therapy. Even though good treatment options are available for CRC, the ultimate therapeutic approach is to avert the incidence of CRC. It was also found that CRCs could be prevented by diet and nutrition such as calcium, vitamin D, curcumin, quercetin and fish oil supplements. Immunotherapy and vaccination are used nowadays which are showing better results against CRC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第2期582-599,共18页 世界胃肠病学杂志(英文版)
关键词 COLORECTAL cancer RECEPTOR based targetedtherapy GENE delivery Colorectal cancer Receptor based targeted therapy Gene delivery
  • 相关文献

参考文献1

二级参考文献16

  • 1Rosenberg SA,Progress in human trmour immunology and immunotherapy.Nature 2001;411;380-384.
  • 2Bonnotte B,Larmonier N,Favre N,Fromentin A,Moutet M,Martin M,Gurbuxani S,Solary E,Chauffert B,Martin F,Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system.J Immunol 2001;167;5077-5083.
  • 3Toujas L,Delcros JG,Diez E,Gervois N,Semana G,Corradin G,Jotereau F,Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides. Immunology 1997;91:635-642.
  • 4Yoshida R, Yoneda Y, Kuriyama M, Kubota T. IFN-gamma and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: An application of allografting to cancer treatment. J Immunol 1999; 163:148-154.
  • 5Reiter I, Krammer B, Schwamberger G. Cutting edge: Differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J Immunol 1999; 163:1730-1732.
  • 6Chert BY, Ma JY, Huang QT, You LF. Simplely natural killing experiment DA kind of modified LDH release assay. Shanghai Mianyixue Zazhi 1989; 9:218-219.
  • 7Zhan Y, Corbett AJ, Brady JL, Sutherland RM, Lew AM. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.J Immunol 2000; 165:3612-3619.
  • 8Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K,Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 2001; 97:1809-1816.
  • 9Bai XF, Bender J, Liu J, Zhang H, Wang Y, Li O, Du P, Zheng P,Liu Y. Local costimulation reinvigorates tumor-specific cytolytic T lymphocytes for experimental therapy in mice with large tumor burdens. J Immunol 2001; 167:3936-3943.
  • 10Koido S, Kashiwaba M, Chen D, Gendler S, Kufe D, Gong J.Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA1. J Immunol 2000; 165:5713-5719.

共引文献1

  • 1Guillermo Mazzolini,Oihana Murillo,Catalina Atorrasagasti,Juan Dubrot,Iigo Tirapu,Miguel Rizzo,Ainhoa Arina,Carlos Alfaro,Arantza Azpilicueta,Carmen Berasain,José L Perez-Gracia,Alvaro Gonzalez,Ignacio Melero.Immunotherapy and immunoescape in colorectal cancer[J].World Journal of Gastroenterology,2007,13(44):5822-5831. 被引量:4

同被引文献26

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部